全部新闻

讨论、会议及分享

网络研讨会和播客

Presentation of annual results for 2023 and ambitions for 2024

22 4 月 2024

Intrasense presents its 2023 annual results.Discover in this webinar the progress of Intrasense's medical imaging solutions, its 2024 objectives and ambitions.

观看视频

Presentation of the half-yearly financial results 2022

21 10 月 2022

To coincide with the publication of its half-year results for 2022, Intrasense will provide an update on its latest developments.

观看视频

Presentation of 2021 annual results and 2022 ambitions

14 3 月 2022

On the occasion of the publication of its 2021 annual results, Intrasense will provide an update on its latest developments.

观看视频

Demo of the new COVID-19 dedicated protocol

2 4 月 2020

This protocol offers numerous clinical advantages, particularly in terms of screening, pathological stage analysis and pathological progression.

观看视频

所有的网络研讨会

新闻稿

Liflow®, a solution dedicated to oncology imaging, wins the JFR 2024 Innovation Prize in the “Healthcare IT and AI” category

30 9 月 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and the developer of Myrian^® and Liflow^®, is proud to announce that its Liflow^® solution has been awarded the Prix Innovation JFR (Journées Francophones de la Radiologie) 2024 in the “Healthcare IT and AI” category.

发现更多

Intrasense announces its half-year results for 2024

25 9 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® et Liflow®, announces its consolidated IFRS half-year results for 2024.

发现更多

Guerbet and Intrasense announce the CE marking of DUOnco™ Liver, an artificial intelligence algorithm designed to detect focal liver lesions

23 9 月 2024

Guerbet (FR0000032526 GBT), worldwide leader in medical imaging, and Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announce the CE marking under MDR of the liver AI developed by Guerbet (trading name: DUOnco™ Liver).

发现更多

Intrasense attends the « Journées Francophones de Radiologie » 2024

9 9 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and Myrian^®and Liflow^®developer, announces its attendance in Journées Francophones de Radiologie (JFR) 2024, where will be presented for the first time the new solution Liflow^® as well as the innovations of the new version of Myrian^®.

发现更多

Alexandre Salvador appointed CEO of Intrasense to accelerate strategic repositioning on high value-added medical solutions integrating AI in radiology

27 8 月 2024

The Board of Directors of Intrasense (FR0011179886 - ALINS), metting on August, 28 2024 at 5:30 pm under the chairmanship of Mr. François NICOLAS, has decided to appoint Mr. Alexandre SALVADOR as Chief Executive Officer of Intrasense.

发现更多

1 2 3 … 21 下一页 »

全部的新闻稿